Rocket Lab’s Iridium Transformation Tests Investor Resolve as Neutron Nears Launch

The space sector’s most talked‑about tie‑up is entering a critical phase. Rocket Lab’s stock has tumbled 28.4% over the past month, landing at €67.60 at Monday’s close, but the headline decline masks a more complex story: the shares remain up 81.7% over the past twelve months and still show a 4% gain since the start of 2026. From the 52‑week high of €133.80 struck on May 27, the equity is now 49.5% lower, while the distance to the November 2025 low of €32.60 amounts to 107.4%. A Relative Strength Index of 34.5 points to oversold conditions, and the annualised 30‑day volatility of roughly 100% underscores the nervous atmosphere surrounding the stock. The market capitalisation stands at approximately €44.4 billion.

The primary driver of the recent weakness is the announced acquisition of Iridium Communications, valued at around $8 billion and structured with a collar that injects considerable uncertainty. Should Rocket Lab’s share price trade between $67.50 and $112.50, Iridium shareholders will receive consideration worth roughly $54 per share in cash and stock. But if the stock sinks below $67.50, the exchange ratio freezes at 0.4000, a scenario that would erode the deal’s value for Iridium holders. Iridium’s own equity is currently pricing in an 11.1% spread to the agreed price, a signal that the market has doubts about a smooth closing. Funding includes a $3.6 billion bridge loan arranged by Deutsche Bank and Wells Fargo, and the transaction requires shareholder, antitrust and regulatory approvals before a hard deadline of June 28, 2027. Iridium brings 66 low‑Earth‑orbit satellites, around 2.5 million subscribers, and 2025 revenue of $871.7 million with a 57% EBITDA margin.

Separately, Rocket Lab is advancing its own launch vehicle, Neutron. Last week the company completed a successful full‑duration burn of the AVac engine for the second stage, which produces 1.2 times the thrust of the first‑stage version. CEO Peter Beck continues to target the first Neutron launch for the fourth quarter of 2026. The company also unveiled the “Hungry Hippo” payload fairing design, in which the two halves remain attached to the first stage, open like a jaw to release the payload, and close again in roughly 1.5 seconds — a configuration intended to cut costs and maximise the 13,000‑kilogram low‑Earth‑orbit capacity. Added momentum came from the VICTUS HAZE mission for the U.S. Space Force, where Rocket Lab achieved launch readiness within about 17 hours of an alert, demonstrating the kind of rapid responsiveness that is increasingly prized by government customers.

Should investors sell immediately? Or is it worth buying Rocket Lab?

The backlog, at $2.2 billion, includes an $816 million contract for missile‑defence satellites and an order for 18 spacecraft from the Space Development Agency. First‑quarter revenue rose more than 63% year on year, and the next earnings report, due on August 6, 2026, will be closely watched for signs that operational momentum is translating into financial results.

Analyst views remain split. Morgan Stanley raised its bull‑case target to $293 from $185 and reiterated an Overweight rating with a base case of $105. Cantor Fitzgerald maintained a Buy with a $96 price target, citing strong demand in a capacity‑constrained launch market and more than 90 successful missions. The consensus range sits between roughly $108 and $113 per share. At the same time, insider selling has attracted attention: Beck disposed of about three million shares within a short period, and total insider sales over the past three months have run into the hundreds of millions of dollars.

On the technical front, the stock is now trading almost exactly at its 200‑day moving average of €67.19. That level represents a critical support line; a break below it could accelerate the selling pressure. For now, the market is weighing the collar mechanics of the Iridium deal against the tangible progress at Neutron — and waiting to see which force wins out.